Skip to content

Risk Factors Analysis for Acute Myocardial Infarction Patients

Clinical Features and Risk Factors Analysis for Acute Myocardial Infarction Patients Received ECMO

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05390658
Enrollment
80
Registered
2022-05-25
Start date
2020-01-11
Completion date
2023-01-12
Last updated
2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMI - Acute Mesenteric Ischemia, Extracorporeal Membrane Oxygenation Complication

Brief summary

ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been increasing year by year, clinical outcomes of AMI remain poor with high in-hospital mortality. Thus, it is necessary to characterize clinical features and investigate potentially modifiable factors contributing to outcomes of AMI patients who received ECMO treatment.

Interventions

OTHERNot application

Not application

Sponsors

Genglong Liu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

Clinical diagnosis of Alzheimer's Disease Age more than 18

Exclusion criteria

Life expectancy \<1 year Prolonged cardiac arrest before VA-ECMO therapy (\>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission

Design outcomes

Primary

MeasureTime frameDescription
Survival rate1 monthSurvival information from ICU entry to ICU exit

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026